Latest Articles

Same rocks. Same region. Similar anomaly. Here’s why we like LYN right now

Catalyst Hunter Feb 06, 2023

The West Arunta Province was put on the map late last year, when WA1 Resources made a niobium/rare earths discovery that sent its share price from ~13.5c to a high of $3.02 per share.

New Year, New Drill: What is happening with IVZ?

Next Investors Feb 03, 2023

Today we will run through all that's happened since our 2020 Energy Pick of the Year Invictus Energy (ASX: IVZ) completed its maiden well, including some impressive new board appointments, and what we expect to happen next.

We just increased our Investment in ALA - Here’s why

Next Investors Feb 02, 2023

A few weeks ago, a child in the UK received a “base edited” cell therapy for leukaemia. The child went into remission (was cured) within four weeks. We also have an investment in the cell therapy space Arovella Therapeutics (ASX:ALA), that could be cheaper, more readily available, and more effective than existing cell therapy treatments.

GAL keeps hitting new mineralised structures - where’s the source?

Next Investors Feb 01, 2023

Galileo Mining (ASX: GAL) made a significant PGE Discovery at Callisto last year, since then, it has been drilling all around the deposit and it continues to expand. The company has just released another set of assays that show an intrusion 250m North of the major Callisto Discovery. It keeps getting longer and deeper, is the company getting closer to the source of this PGE Discovery?

WHK Quarterly: We are pleasantly surprised - here’s why

Next Investors Jan 31, 2023

Our 2019 Technology Pick of the Year, Whitehawk Limited (ASX: WHK), has just announced its' quarterly results to the market. In the market announcement, we noticed a steady growth in revenue and sales of the cybersecurity products with a potential pipeline of new materialistic deals.

Can ONE deliver contracts as we emerge from the 2022 tech wreck?

Next Investors Jan 30, 2023

Our healthtech Investment, and 2021 Tech Pick of the Year, Oneview Healthcare (ASX:ONE) released its latest quarterly today and it showed us how ONE has adapted during a tough time for tech.

How the mainstream news shapes the macro themes we invest in

Next Investors Jan 28, 2023

In this weekly wrap, we look at the various outlooks presented by the media toward our key investment themes such as; biotechs, resources and technology companies.

Why is the EV1 share price running?

Wise-Owl Jan 27, 2023

Evolution Energy Minerals (ASX: EV1) was our Wise Owl Pick of the Year 2021, and recently we have seen the share price of the company rising. In this email, we uncover some upcoming catalysts for the company that may drive new interest in EV1.

Big funding decision looming: The catalyst FYI is looking for?

Wise-Owl Jan 25, 2023

In 2023 we are focusing on development stage resource companies that are close to becoming “producers” during this commodities super cycle. Our ~$60M-capped, Wise-Owl critical metals Investment, FYI Resources (ASX:FYI) has a clear pathway to project financing for its innovative high purity alumina (HPA) project.

LRS now drilling west of its lithium JORC resource

Catalyst Hunter Jan 24, 2023

Latin Resources’ (ASX: LRS) has just released some more lithium assays and the geology manager says that they are “on par” or “better than” the main deposit...

Page 1 of 77 next >